Alibaba
BABA
Meta Platforms
META
Taiwan Semiconductor
TSM
4
Oracle
ORCL
5
ASML Holding
ASML
US Stock MarketDetailed Quotes
TXMD TherapeuticsMD
- 1.420
- +0.030+2.16%
Close May 2 16:00 ET
- 1.362
- -0.058-4.10%
Post 20:01 ET
16.44MMarket Cap-7.47P/E (TTM)
1.470High1.350Low85.66KVolume1.400Open1.390Pre Close121.33KTurnover0.90%Turnover RatioLossP/E (Static)11.57MShares2.44052wk High0.60P/B13.51MFloat Cap0.70052wk Low--Dividend TTM9.51MShs Float7999.999Historical High--Div YieldTTM8.63%Amplitude0.700Historical Low1.416Avg Price1Lot Size
TherapeuticsMD Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 105.07%1.17M | 100.34%17K | 98.82%-71K | 142.84%1.45M | 97.37%-229K | -346.43%-23.08M | -116.40%-4.96M | -134.03%-6.03M | 83.63%-3.39M | 51.31%-8.7M |
| Net income from continuing operations | 69.97%-2.31M | 107.40%114K | 60.46%-567K | 56.50%-1.05M | 64.98%-809K | -816.85%-7.7M | -103.18%-1.54M | 90.20%-1.43M | 83.77%-2.41M | 87.08%-2.31M |
| Depreciation and amortization | -44.79%509K | -84.30%100K | -25.58%96K | 39.53%180K | 392.59%133K | -23.17%922K | 101.58%637K | -52.75%129K | -54.26%129K | -91.79%27K |
| Other non cash items | -69.77%-219K | -20.95%-791K | -67.50%196K | 1,155.56%190K | 410.00%186K | 67.83%-129K | -73.94%-654K | 6,130.00%603K | -125.00%-18K | -757.14%-60K |
| Change In working capital | 109.52%1.66M | 116.28%563K | 103.08%171K | 150.82%776K | 102.17%150K | -326.97%-17.45M | 83.64%-3.46M | -120.01%-5.56M | 81.73%-1.53M | -189.92%-6.9M |
| -Change in prepaid assets | -80.14%397K | -88.27%380K | 62.83%-517K | -68.81%500K | 102.34%34K | 222.42%2M | 1,333.63%3.24M | -114.79%-1.39M | 115.93%1.6M | -238.12%-1.45M |
| -Change in payables and accrued expense | 95.66%-775K | 85.06%-667K | 104.34%233K | 98.92%-40K | 93.04%-301K | -684.99%-17.85M | 68.11%-4.46M | -128.79%-5.37M | -301.53%-3.69M | -25.93%-4.32M |
| -Change in other current assets | 271.40%1.93M | 102.42%56K | -14.84%614K | 30.64%631K | 3,410.53%629K | 85.25%-1.13M | 69.74%-2.31M | --721K | --483K | ---19K |
| -Change in other current liabilities | 122.93%108K | 944.74%794K | -133.26%-159K | -488.89%-315K | 80.83%-212K | -289.26%-471K | -71.21%76K | 283.85%478K | 164.80%81K | ---1.11M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 105.07%1.17M | 100.34%17K | 98.82%-71K | 142.84%1.45M | 97.37%-229K | -346.62%-23.08M | -116.40%-4.96M | -134.03%-6.03M | 83.63%-3.39M | 51.31%-8.7M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 101.34%3.15M | 101.79%2M | -100.06%-1K | ||||
| Net common stock issuance | --0 | --0 | --0 | ---- | ---- | 27.67%3.15M | 14,200.00%2M | -100.04%-1K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | ---- | ---- | 101.34%3.15M | 101.79%2M | -100.06%-1K | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -91.23%4.33M | -50.35%5.05M | -61.89%5.23M | -74.85%4.34M | -91.23%4.33M | -24.27%49.32M | -73.48%10.17M | -47.80%13.73M | -43.23%17.25M | -24.27%49.32M |
| Current changes in cash | 101.63%732K | 100.21%12K | 94.81%-185K | 125.40%894K | 100.03%11K | -184.66%-44.99M | -153.14%-5.84M | -129.63%-3.56M | 13.77%-3.52M | 7.68%-32.07M |
| End cash Position | 16.92%5.06M | 16.92%5.06M | -50.35%5.05M | -61.89%5.23M | -74.85%4.34M | -91.23%4.33M | -91.23%4.33M | -73.48%10.17M | -47.80%13.73M | -43.23%17.25M |
| Free cash flow | 105.07%1.17M | 100.34%17K | 98.82%-71K | 142.84%1.45M | 97.37%-229K | -356.34%-23.08M | -116.44%-4.96M | -134.01%-6.03M | 83.69%-3.39M | 51.89%-8.7M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call